Tag Archives: Magenta Therapeutics Inc.

Eight biotechs swarm into Nasdaq, raising $796 million as the IPO raindance shows no signs of abating. My take on which resemble rational wagers versus blind bets.

      No Comments on Eight biotechs swarm into Nasdaq, raising $796 million as the IPO raindance shows no signs of abating. My take on which resemble rational wagers versus blind bets.

In recent years, biotech IPOs came one, or maybe two, most weeks. But in 2018, things are very different. Last week, a mind boggling eight were priced, simultaneously testing investors’ appetite… Read more »

2018 biotech IPOs still on a tear, with 25 already priced; 8 new filings last week alone.

      No Comments on 2018 biotech IPOs still on a tear, with 25 already priced; 8 new filings last week alone.

In all my 26 years at MondayMorning, never have I witnessed such a massive, mad dash for the IPO filing window, and the SEC must be wondering if and when… Read more »